Rare NRXN1 promoter variants in patients with schizophrenia

被引:16
|
作者
Shah, Abhishek K. [1 ]
Tioleco, Nina M. [1 ]
Nolan, Karen [2 ,3 ]
Locker, Joseph [4 ]
Groh, Katherine [1 ]
Villa, Catalina [1 ]
Stopkova, Pavla [5 ]
Pedrosa, Erika [1 ]
Lachman, Herbert M. [1 ]
机构
[1] Albert Einstein Coll Med, Basic Res Div, Dept Psychiat & Behav Sci, Bronx, NY 10461 USA
[2] Nathan S Kline Inst Psychiat Res, Orangeburg, NY 10962 USA
[3] NYU, Sch Med, Dept Psychiat, New York, NY USA
[4] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10461 USA
[5] Prague Psychiat Ctr, Prague, Czech Republic
关键词
Neurexin; Schizophrenia; Bipolar disorder; Autism; CNV; Copy variant; TRANSCRIPTION FACTOR; ALPHA-NEUREXINS; GENE; ASSOCIATION; EXPRESSION; APOPTOSIS;
D O I
10.1016/j.neulet.2010.03.047
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Copy number variants (CNVs) affecting the neurexin 1 (NRXN1) gene have been found in a subgroup of patients with schizophrenia (SZ). NRXN1 expression is complex, with multiple alternative splice forms generated from two major transcripts; NRXN1 alpha and NRXN1 beta. The majority of CNVs in SZ are deletions affecting the proximal NRXN1 alpha exons and promoter region. Rare chromosomal events are useful in understanding the genetic basis of complex psychiatric disorders since affected genes become feasible targets to analyze for more subtle genetic alterations. As a first step towards this goal, we resequenced the NRXN1 alpha promoter region in 170 patients with SZ and a similar number of controls. Two rare mutations were identified in the patient population. One previously unknown single nucleotide polymorphism (SNP) was found in controls. Bioinformatics analysis suggests that binding to several transcription factors may be affected by the minor alleles. The findings suggest that in addition to chromosomal alterations disrupting the NRXN1 alpha promoter, rare point mutations in the region may also be involved in SZ pathogenesis. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:80 / 84
页数:5
相关论文
共 50 条
  • [21] COMMON VARIANTS OF NRXN1, LRP1B AND RORA ARE ASSOCIATED WITH INCREASED VENTRICULAR VOLUMES IN SCHIZOPHRENIA AND BIPOLAR DISORDER
    Alliey, Ney
    Gershon, Elliot
    Grey, Tamar A.
    Shafee, Rebecca
    Tandon, Neeraj
    Coppes, Lucas
    Keedy, Sarah
    McCarroll, Steven
    Pearlson, Godfrey
    Keshavan, M.
    Clementz, Brett A.
    Tamminga, C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S924 - S925
  • [22] Analyzing schizophrenia-related phenotypes in mice caused by autoantibodies against NRXN1? in schizophrenia
    Shiwaku, Hiroki
    Katayama, Shingo
    Gao, Mengxuan
    Kondo, Kanoh
    Nakano, Yuri
    Motokawa, Yukiko
    Toyoda, Saori
    Yoshida, Fuyuko
    Hori, Hiroaki
    Kubota, Tetsuo
    Ishikawa, Kinya
    Kunugi, Hiroshi
    Ikegaya, Yuji
    Okazawa, Hitoshi
    Takahashi, Hidehiko
    BRAIN BEHAVIOR AND IMMUNITY, 2023, 111 : 32 - 45
  • [23] An increased burden of rare exonic variants in NRXN1 microdeletion carriers is likely to enhance the penetrance for autism spectrum disorder
    Cameli, Cinzia
    Viggiano, Marta
    Rochat, Magali J.
    Maresca, Alessandra
    Caporali, Leonardo
    Fiorini, Claudio
    Palombo, Flavia
    Magini, Pamela
    Duardo, Renee C.
    Ceroni, Fabiola
    Scaduto, Maria C.
    Posar, Annio
    Seri, Marco
    Carelli, Valerio
    Visconti, Paola
    Bacchelli, Elena
    Maestrini, Elena
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (05) : 2459 - 2470
  • [24] Comparative genome hybridization suggests a role for NRXN1 and APBA2 in schizophrenia
    Kirov, George
    Gumus, Dilihan
    Chen, Wei
    Norton, Nadine
    Georgieva, Lyudmila
    Sari, Murat
    O'Donovan, Michael C.
    Erdogan, Fikret
    Owen, Michael J.
    Ropers, Hans-Hilger
    Ullmann, Reinhard
    HUMAN MOLECULAR GENETICS, 2008, 17 (03) : 458 - 465
  • [25] Identification of Candidate Single-Nucleotide Polymorphisms in NRXN1 Related to Antipsychotic Treatment Response in Patients with Schizophrenia
    Jenkins, Aaron
    Apud, Jose A.
    Zhang, Fengyu
    Decot, Heather
    Weinberger, Daniel R.
    Law, Amanda J.
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 (09) : 2170 - 2178
  • [26] Identification of Candidate Single-Nucleotide Polymorphisms in NRXN1 Related to Antipsychotic Treatment Response in Patients with Schizophrenia
    Aaron Jenkins
    José A Apud
    Fengyu Zhang
    Heather Decot
    Daniel R Weinberger
    Amanda J Law
    Neuropsychopharmacology, 2014, 39 : 2170 - 2178
  • [27] ANALYSING SCHIZOPHRENIA RISK VARIANTS IN NRXN1 USING FUNCTIONAL AND MATURE NEURONAL CULTURES FROM PATIENT-DERIVED IPS CELLS
    Jung, Matthias
    Majer, Annika
    Reinsch, Jessica
    Schiller, Jovita
    Hartmann, Annette
    Konte, Bettina
    Giegling, Ina
    Rujescu, Dan
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : 1335 - 1336
  • [28] Sequence Analysis of 17 NRXN1 Deletions
    Hoeffding, Louise Kristine Enggaard
    Hansen, Thomas
    Ingason, Andres
    Doung, Linh
    Thygesen, Johan H.
    Moller, Rikke S.
    Tommerup, Niels
    Kirov, George
    Rujescu, Dan
    Larsen, Lars A.
    Werge, Thomas
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2014, 165 (01) : 52 - 61
  • [29] Neurexin 1 (NRXN1) Gene Expression across the Normal Human Lifespan: Implications for Neurodevelopment and Schizophrenia
    Jenkins, Aaron
    Wang, Yanhong
    Hyde, Thomas
    Kleinman, Joel
    Law, Amanda
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 65S - 65S
  • [30] Analysing schizophrenia risk variants in NRXN1 using functional and mature neuronal cultures from patient-derived iPS cells
    Jung, M.
    Pfeifer, J.
    Majer, A.
    Reinsch, J.
    Flegel, N.
    Puls, A.
    Hartmann, A.
    Konte, B.
    Giegling, I
    Rujescu, D.
    PHARMACOPSYCHIATRY, 2020, 53 (02) : 86 - 86